Clinical Trial Update: A Trial of Thalidomide, Celecoxib, Etoposide and Cyclophosphamide in Patients With Relapsed or Progressive Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating thalidomide, celecoxib, etoposide, and cyclophosphamide in patients with relapsed or progressive cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neoplasms

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Celecoxib (Celecoxib)
• Etoposide (Etoposide)
• Thalidomide (thalidomide)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Neoplasms | Phase 2 | Status: COMPLETED